An increasing number of tissue biomarkers that can target cells, tissue morphology, and protein expression have been used in clinical practice to aid in disease diagnosis, assess patient prognosis, and formulate treatment planning by predicting individual patient response to treatment. Ace Therapeutics offers immunohistochemistry (IHC) techniques, tissue microarrays, histology and digital pathology methods, and imaging analysis to study ocular tissue biomarkers.
In ophthalmology, tissue samples testing is a valuable substrate for testing biomarkers. Ace Therapeutics has been proud to help global clients develop medicines, and tissue analysis is one of our core specialties. Our expertise in tissue greatly helps our partners.
Our scientists help our partners meet their tissue analysis requirements by leveraging our experience with automated homogenization, manual homogenization, homogenization buffer optimization, and the species and tissue types we have experience with. Our expert team has been busy with the discovery, analysis and validation of ocular tissue biomarkers in the field of ophthalmology.
Ace Therapeutics' team has been supporting ocular tissue research. We have the knowledge, instruments and experience to provide you with reliable data. You only need to send your samples, and we provide a series of services such as tissue homogenization, immunohistochemistry, microarray, histology, digital pathology and image analysis. We are excited to bring light by helping our partners develop medicines.
Immunohistochemistry (IHC), using monoclonal and polyclonal antibodies to detect specific antigens in situ, is a very powerful tool for imaging discrete components in tissues. The science at Ace Therapeutics is constantly evolving, as evidenced by the development of our increasingly sophisticated automated staining platform, the production of specific antibodies against a broad range of species, and the availability of an array of ocular novel biomarkers. We have a range of immunohistochemical markers optimized for paraffin-embedded tissue and a variety of fluorescent detection techniques to analyze your ocular tissue samples.
Tissue microarray (TMA) is a high-throughput analysis technique for tissue samples. Our ocular tissue team is able to easily perform high-throughput biomarker analysis of customer samples, which can be used for diagnostic analysis, evaluation of predictive or prognostic biomarkers, detection of disease biology, and target identification of new methods.
Our digital pathology and image analysis services offer detection of ocular tissue, whole slide scanning, powerful software and computer processing power. This enables us to discover and analyze potential ocular tissue biomarkers. Our services enable researchers to accelerate quantitative biomarker discovery and transform the discovery and clinical translation of companion diagnostics for precision medicine.
Ace Therapeutics is dedicated to serving customers around the world. Our scientists stand ready to provide high-quality ocular tissue biomarker solutions to customers. In addition to this, we offer highly customized services including tissue microarrays and other histology and digital pathology technologies to identify and validate tissue biomarkers.. If you have any questions about the content of this service, please feel free to contact us. We look forward to hearing from you.